Cannabis use and misuse prevalence among people with psychosis

被引:145
作者
Green, B
Young, R
Kavanagh, D
机构
[1] Community Forens Mental Hlth Serv, Brisbane, Qld 4001, Australia
[2] Queens Univ Technol, Fac Hlth, Sch Psychol & Counselling, Carseldine, Australia
[3] Univ Queensland, Cent Clin Div, Dept Psychiat, Brisbane, Qld 4067, Australia
关键词
D O I
10.1192/bjp.187.4.306
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Increasing attention has been given by researchers to cannabis use in individuals with psychosis. As psychoses are relatively low-prevalence disorders, research has been mostly been restricted to small-scale studies of treatment samples.The reported prevalence estimates obtained from these studies vary widely Aims To provide prevalence estimates based on larger samples and to examine sources of variability in prevalence estimates across studies. Method Data from 53 studies of treatment samples and 5 epidemiological studies were analysed. Results Based on treatment sample data, prevalence estimates were calculated for current use (23.0%), current misuse (11.3%),12-month use (29.2%),12month misuse (18.8%), lifetime use (42. 1 %) and lifetime misuse (22.5%). Epidemiological studies consistently reported higher cannabis use and misuse prevalence in people with psychosis. Conclusions The factor most consistently associated with increased odds of cannabis prevalence was specificity of diagnosis. Factors such as consumption patterns and study design merit further consideration. Declaration of interest None.
引用
收藏
页码:306 / 313
页数:12
相关论文
共 77 条
[1]  
[Anonymous], 2002, Psychiatric Bulletin, DOI DOI 10.1192/PB.26.7.248
[2]  
[Anonymous], EUR ADDICT RES
[3]   COMORBIDITY OF SUBSTANCE-ABUSE AND SCHIZOPHRENIA - THE ROLE OF PREMORBID ADJUSTMENT [J].
ARNDT, S ;
TYRRELL, G ;
FLAUM, M ;
ANDREASEN, NC .
PSYCHOLOGICAL MEDICINE, 1992, 22 (02) :379-388
[4]   Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study [J].
Arseneault, L ;
Cannon, M ;
Poulton, R ;
Murray, R ;
Caspi, A ;
Moffitt, TE .
BRITISH MEDICAL JOURNAL, 2002, 325 (7374) :1212-1213
[5]  
*AUSTR I HLTH WELF, 2002, 2001 NAT DRUG STRAT
[6]   Cannabis and schizophrenia:: impact on onset, course, psychopathology and outcomes [J].
Bersani, G ;
Orlandi, V ;
Kotzalidis, GD ;
Pancheri, P .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2002, 252 (02) :86-92
[7]   Substance use disorders in schizophrenia: Review, integration, and a proposed model [J].
Blanchard, JJ ;
Brown, SA ;
Horan, WP ;
Sherwood, AR .
CLINICAL PSYCHOLOGY REVIEW, 2000, 20 (02) :207-234
[8]   Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis [J].
Brewer, WJ ;
Pantelis, C ;
Anderson, V ;
Velakoulis, D ;
Singh, B ;
Copolov, DL ;
McGorry, PD .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (01) :107-115
[9]   Substance abuse in schizophrenia:: a review of the literature and a study of correlates in Sweden [J].
Cantor-Graae, E ;
Nordström, LG ;
McNeil, TF .
SCHIZOPHRENIA RESEARCH, 2001, 48 (01) :69-82
[10]   Prevalence of substance misuse in first-episode psychosis [J].
Cantwell, R ;
Brewin, J ;
Glazebrook, C ;
Dalkin, T ;
Fox, R ;
Medley, I ;
Harrison, G .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 :150-153